Insmed (INSM) Enterprise Value (2010 - 2026)
Insmed (INSM) recorded Enterprise Value of $24.91 billion in Q3 2026, down 13.9% from $28.93 billion a year earlier but up 12.7% from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Enterprise Value (2010 - 2026) Analysis & Trends
For FY2025, Insmed reported Enterprise Value of $35.86 billion, up 227.5% from FY2024.
- Annual Enterprise Value has increased for three straight years, with a five-year compound annual growth rate of 65.5% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $10.95 billion in FY2024 (+187.8%), $3.81 billion in FY2023 (+143.6%), $1.56 billion in FY2022 (-38.0%) and $2.52 billion in FY2021 (-12.8%).
- Quarterly Enterprise Value has ranged from $1.33 billion in Q1 2023 to $35.86 billion in Q4 2025 over the past five years.
- On a year-over-year basis, Enterprise Value rose in seven of the last eight quarters, with growth averaging 137.4%.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 373.7% in Q2 2024, against a decline of 38.8% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $22.11 billion (Q2 2026), $34.18 billion (Q1 2026) and $35.86 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Insmed | 25.82 Bn | 20.86 Bn | 446.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 23.77 Bn |
| Jun 30, 2026 | 22.11 Bn |
| Mar 31, 2026 | 34.18 Bn |
| Dec 31, 2025 | 35.86 Bn |
| Sep 30, 2025 | 28.93 Bn |
| Jun 30, 2025 | 19.39 Bn |
| Mar 31, 2025 | 12.68 Bn |
| Dec 31, 2024 | 10.95 Bn |
| Sep 30, 2024 | 11.59 Bn |
| Jun 30, 2024 | 9.92 Bn |
| Mar 31, 2024 | 3.43 Bn |
| Dec 31, 2023 | 3.81 Bn |
| Sep 30, 2023 | 2.83 Bn |
| Jun 30, 2023 | 2.09 Bn |
| Mar 31, 2023 | 1.33 Bn |
| Dec 31, 2022 | 1.56 Bn |
| Sep 30, 2022 | 2.11 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 2.17 Bn |
| Dec 31, 2021 | 2.52 Bn |
API Access
Insmed Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();